A paradigm shift for erythropoietin: no longer a specialized growth factor, but rather an all-purpose tissue-protective agent.
Savino
R
R
Ciliberto
G
G
D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology; D002470:Cell Survival / Q000187:drug effects / Q000502:physiology; D019610:Cytoprotection / Q000502:physiology*; D042783:Endothelial Cells / Q000187:drug effects; D004847:Epithelial Cells / Q000187:drug effects; D004921:Erythropoietin / Q000494:pharmacology / Q000502:physiology* / Q000627:therapeutic use; D006801:Humans; D007422:Intestines / Q000187:drug effects; D007684:Kidney Tubules / Q000166:cytology; D032383:Myocytes, Cardiac / Q000187:drug effects; D018696:Neuroprotective Agents / Q000494:pharmacology / Q000627:therapeutic use; D012867:Skin / Q000187:drug effects; D020196:Trauma, Nervous System / Q000188:drug therapy
D018696:Neuroprotective Agents; D004921:Erythropoietin